1. Signaling Pathways
  2. Cytoskeleton
  3. Integrin
  4. α5β1 Isoform

α5β1

 

α5β1 Related Products (6):

Cat. No. Product Name Effect Purity
  • HY-15102
    MK-0429
    Antagonist 99.84%
    MK-0429 (L-000845704) is an orally active, potent, selective and nonpeptide pan-integrin antagonist with IC50 values of 1.6 nM, 2.8 nM, 0.1 nM, 0.7 nM, 0.5 nM and 12.2 nM for αvβ1, αvβ3, αvβ5, αvβ6, αvβ8 and α5β1, respectively.
  • HY-P1740A
    RGD peptide (GRGDNP) (TFA)
    Inhibitor 99.41%
    RGD peptide (GRGDNP) TFA is an inhibitor of integrin-ligand interactions.
  • HY-P1189A
    Echistatin TFA
    Antagonist
    Echistatin TFA, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation.
  • HY-P1740
    RGD peptide (GRGDNP)
    Inhibitor
    RGD peptide (GRGDNP) is an inhibitor of integrin-ligand interactions.
  • HY-P1189
    Echistatin
    Antagonist
    Echistatin, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation.
  • HY-150124
    K34c
    Antagonist
    K34c is a potent and selective α5β1 integrin antagonist.